Global Healthcare Intelligence/Markets/Regulatory Navigator/Global

GLOBAL HEALTHCARE INTELLIGENCE

Intelligence Search

Discover official-source briefs, safety alerts and procurement opportunities. Guidance status describes source material, not product authorization.

20 intelligence briefs / safety alerts

CURRENT

Advertising lists: official-source notice

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing · Regulatory Affairs · Compliance

PharmaceuticalsMedical Devices & IVDsCosmetics
View intelligence briefVerified 2026-10-07
CURRENT

Innovative-product registration — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Product developers · Manufacturers · Regulatory Affairs teams

PharmaceuticalsBiological Products
View intelligence briefVerified 2026-10-07
NEW / UPDATED

Advertising compliance: official violations list

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing · Regulatory Affairs · Compliance

PharmaceuticalsMedical Devices & IVDsCosmetics
View intelligence briefVerified 2026-10-07
SAFETY ALERT

Captopril — 2026-08

SAFETY ALERT

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing Authorization Holders · Pharmacovigilance teams · Regulatory Affairs

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

Clinical-trial oversight — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Clinical-trial sponsors · CROs · Investigators

Biological ProductsPharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

Biological reliance pathways — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Biological-product applicants · Manufacturers · Regulatory Affairs teams

Biological Products
View intelligence briefVerified 2026-10-07
CURRENT

WHO Prequalification of Pharmaceutical Products

INTELLIGENCE BRIEF

World Health Organization (WHO) · International Procurement

Affected: Manufacturers · Suppliers / Wholesale Distributors · Exporters

Pharmaceuticals
View intelligence briefVerified 2026-10-07
NEW / UPDATED

Generic medicines / Bioequivalence — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Generic pharmaceutical manufacturers · Marketing Authorization Holders · Regulatory Affairs teams

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

Biological dossier content — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Biological-product manufacturers · Marketing Authorization Holders · Regulatory Affairs teams

Biological Products
View intelligence briefVerified 2026-10-07
CURRENT

Medical Device UDI — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Manufacturers · Agents · Importers

Medical Devices & IVDs
View intelligence briefVerified 2026-10-07
CURRENT

Import & medical customs release — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Manufacturers · Exporters · Importers

PharmaceuticalsBiological ProductsMedical Devices & IVDsCosmetics
View intelligence briefVerified 2026-10-07
SAFETY ALERT

Vancomycin — 2026-04

SAFETY ALERT

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing Authorization Holders · Pharmacovigilance teams · Regulatory Affairs

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

Imported product shelf life — 2026

INTELLIGENCE BRIEF

Egyptian Drug Authority (EDA) · Egypt

Affected: Foreign manufacturers · Exporters · Importers

PharmaceuticalsBiological Products
View intelligence briefVerified 2026-10-07
SAFETY ALERT

Leflunomide — 2026-03

SAFETY ALERT

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing Authorization Holders · Pharmacovigilance teams · Regulatory Affairs

Pharmaceuticals
View intelligence briefVerified 2026-10-07
SAFETY ALERT

Bisoprolol — 2026-02

SAFETY ALERT

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing Authorization Holders · Pharmacovigilance teams · Regulatory Affairs

Pharmaceuticals
View intelligence briefVerified 2026-10-07
SAFETY ALERT

Ibrutinib — 2026-01

SAFETY ALERT

Egyptian Drug Authority (EDA) · Egypt

Affected: Marketing Authorization Holders · Pharmacovigilance teams · Regulatory Affairs

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

Dietary supplement / NFSA navigator

INTELLIGENCE BRIEF

National Food Safety Authority (NFSA) · Egypt

Affected: Dietary-supplement businesses · Manufacturers · Importers

Nutraceuticals / Dietary Supplements
View intelligence briefVerified 2026-10-07
CURRENT

Generic Medicines — WHO Prequalification Readiness

INTELLIGENCE BRIEF

World Health Organization (WHO) · International Procurement

Affected: Manufacturers · Suppliers / Wholesale Distributors · Exporters

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

WHO Procurement Quality Assurance

INTELLIGENCE BRIEF

World Health Organization (WHO) · International Procurement

Affected: Manufacturers · Suppliers / Wholesale Distributors · Exporters

Pharmaceuticals
View intelligence briefVerified 2026-10-07
CURRENT

WHO ePQS Portal

INTELLIGENCE BRIEF

World Health Organization (WHO) · International Procurement

Affected: Manufacturers · Suppliers / Wholesale Distributors · Exporters

Pharmaceuticals
View intelligence briefVerified 2026-10-07

Procurement Opportunities

4 verified notices

CLOSING SOONWHO

SPECIALIZED PROFESSIONAL OPPORTUNITY

WHO Prequalification Assessment for Medical Devices — Request for Quotations from Notified Bodies

Professional / Regulatory Services · International

DeadlineGeneva time / CEST (GMT+2)

Published 2026-09-04 · RFQ

Eligibility: European / EU Notified Bodies with proven medical-device and IVD assessment experience, as stated by WHO.

Reference: 2026_RFQ_PQT_AMD_002

Last verified 2026-10-07

CLOSING SOONUNICEF

Supplementary Food

Nutrition · Multiple Destinations

DeadlineCopenhagen time / GMT+2

Published 2026-09-16 · RFP

Eligibility: Product, technical, quality, commercial and supply requirements are defined in the official UNICEF RFP.

Reference: RFP-DAN-2026-503954

Last verified 2026-10-07

LIVEWHO

Procurement of CPHL Laboratory Equipment, Cairo — Egypt

Laboratory Equipment · Egypt

DeadlineCairo time / GMT+3

Published 2026-10-04 · ITB

Eligibility: Restricted to Local Egyptian Suppliers

Reference: EM/ACO/EGY/P/0009587

Last verified 2026-10-07

LIVEUNICEF

Establishing Long Term Agreements for Supply of Various Essential Medicines

Pharmaceuticals · Multiple Destinations

DeadlineGMT+11 (official notice)

Published 2026-07-17 · RFP

Eligibility: Review the official RFP for full supplier and product eligibility. UNGM registration level: Basic.

Reference: RFP-DAN-2026-503933

Last verified 2026-10-07

Regulatory NavigatorProcurement Watch
VERIFIED SOURCE GOVERNANCE

Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.

How we verify intelligence

Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.

Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.